The ACC has endorsed Million Hearts’ new Cardiovascular Risk Reduction Model – the first of its kind from the Centers for Medicare and Medicaid Services. The model is structured as a randomized trial made up of Medicare Fee for Service beneficiaries from 360 control and 360 intervention practices, combining for roughly 150,000 subjects in each arm. Using a data-driven, predictive modelling approach, each participant will  receive an individualized 10-year risk score that can then be leveraged by both providers and the patient to explore various treatment options, such as lowering blood pressure, ending a smoking habit or implementing a statin/aspirin regimen. Practices will be required to re-stratify the patient's risk regularly, and follow it over time. In terms of payment, the model's value-based payment design will reward statistical reduction in predicted risk of heart attack and stroke, rather than specific blood pressure or cholesterol numbers. Participating doctors will be paid based on the actual reduction of the absolute risk of their entire panel, increasing incentives to manage high-risk patients. Practice enrollment began in June, with a planned performance to start in January 2016, which will last for five years. For more information and to enroll, visit the program website or email mhmodel@cms.hhs.gov. Read more on ACC.org.